Výsledky vyhledávání - David Rizzeri
- Zobrazuji výsledky 1 - 2 z 2
-
1
Phase II, multicenter, randomized trial of CPX‐351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML Autor Jorge E. Cortés, Stuart L. Goldberg, Eric J. Feldman, David Rizzeri, Donna E. Hogge, Melissa L. Larson, Arnaud Pigneux, Christian Récher, Gary J. Schiller, Krzysztof Warzocha, Hagop M. Kantarjian, Arthur C. Louie, Jonathan E. Kolitz
Vydáno 2014Artigo -
2
An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemia Autor Jeevisha Bajaj, Michael Hamilton, Yutaka Shima, Kendall R. Chambers, Kyle Spinler, Eric L. Van Nostrand, Brian A. Yee, Steven M. Blue, Michael Chen, David Rizzeri, Charles Chuah, Vivian G. Oehler, H. Elizabeth Broome, Roman Šášik, James Scott‐Browne, Anjana Rao, G Yeo, Tannishtha Reya
Vydáno 2020Artigo
Vyhledávací nástroje:
Související témata
Biology
CRISPR
Cancer research
Chemotherapy
Chemotherapy regimen
Chromatin
Clinical endpoint
Cytarabine
Environmental health
Gene
Genetics
Immunology
Internal medicine
Leukemia
Medicine
Myeloid
Myeloid leukemia
Oncology
Population
Randomized controlled trial
Regimen
Regulator
Salvage therapy
Surgery